Alpha 2.0
Login Register
» Authors » Angela Paes

Angela Paes

Explore the profile of Angela Paes including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 27
Followers 0
Related Specialties
Cardiology & Vascular Diseases
Tropical Medicine
Top 10 Co-Authors
Rodolfo Staico
Alexandre Abizaid
J Eduardo Sousa
Amanda G M R Sousa
Marinella Centemero
Fausto Feres
Ibraim Pinto
Luiz F Tanajura
Aurea J Chaves
Gary S Mintz
Published In
Arq Bras Cardiol
Circulation
Rev Inst Med Trop Sao Paulo
Catheter Cardiovasc Interv
Affiliations
Soon will be listed here.
Recent Articles
1.
A real-time quantitative assay for hepatitis B DNA virus (HBV) developed to detect all HBV genotypes
Sitnik R, Paes A, Mangueira C, Pinho J
Rev Inst Med Trop Sao Paulo . 2010 Jul; 52(3):119-24. PMID: 20602019
Hepatitis B virus (HBV) is a major cause of chronic liver disease worldwide. Besides genotype, quantitative analysis of HBV infection is extensively used for monitoring disease progression and treatment. Affordable...
2.
[Adenosine myocardial perfusion SPECT with Tc-99m-MIBI in patients with obstructive coronary artery disease: correlation between quantitative coronary angiography and intravascular ultrasound measurements]
Mastrocolla L, Sousa A, Smanio P, Staico R, Pinto I, Meneghelo R, et al.
Arq Bras Cardiol . 2006 Feb; 86(1):3-13. PMID: 16491203
Objective: To correlate myocardial perfusion scintigraphy (MPS) with Tc-99m-MIBI and adenosine infusion using quantitative coronary angiography (QCA) and intravascular ultrasound (IVUS). Methods: Seventy patients with coronary artery disease (CAD) referred...
3.
Pilot study with an intensified oral sirolimus regimen for the prevention of in-stent restenosis in de novo lesions: a serial intravascular ultrasound study
Chaves A, Sousa A, Mattos L, Abizaid A, Feres F, Staico R, et al.
Catheter Cardiovasc Interv . 2005 Nov; 66(4):535-40. PMID: 16283682
This pilot study evaluated the safety and efficacy of an intensified oral sirolimus regimen (15-mg loading dose 24 hr before PCI, followed by a daily dose of 5 mg for...
4.
[Comparative assessment of the prognostic value of four biochemical markers of myocardial damage after percutaneous coronary stenting]
Centemero M, Sousa A, Staico R, Abizaid A, Feres F, Tanajura L, et al.
Arq Bras Cardiol . 2004 Dec; 83 Spec No:53-8. PMID: 15608990
No abstract available.
5.
Volumetric analysis of in-stent intimal hyperplasia in diabetic patients treated with or without abciximab: results of the Diabetes Abciximab steNT Evaluation (DANTE) randomized trial
Chaves A, Sousa A, Mattos L, Abizaid A, Staico R, Feres F, et al.
Circulation . 2004 Feb; 109(7):861-6. PMID: 14757690
Background: In diabetic patients in the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) trial, abciximab reduced target vessel revascularization by approximately 50% compared with placebo. Whether this is a...